The prevalence of metabolic syndrome in Taiwan has been increasing yearly. In this project, the database of blood test results from healthy and metabolic syndromes individuals will be analyzed to identify the small molecules related to the severity of metabolic syndrome. These identified small molecules could be used as biomarkers to predict the development of metabolic syndromes in the future.
Capable adults weigh ≥ 50 kg
Not Taiwanese
Having received oral antibiotics, immunosuppressants, and chemotherapy drugs in the past month
Incapacity
Limited disposing capacity
Healthy individuals and patients with metabolic syndrom.
Case-control
Prospective
Not listed
Concentration changes of small molecules in blood.
Concentrations of small molecules in healthy individuals and metabolic syndrom patients will be analyzed to identify specific biomarkers for metabolic syndrome.
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
